• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物对慢性阻塞性肺疾病患者肺动脉高压的保护作用:一项全国性回顾性、匹配队列研究。

Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study.

机构信息

Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

出版信息

Sci Rep. 2020 Feb 20;10(1):3104. doi: 10.1038/s41598-020-59828-0.

DOI:10.1038/s41598-020-59828-0
PMID:32080265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7033169/
Abstract

In Taiwan, patients with pulmonary hypertension (PH) related to chronic obstructive pulmonary disease (COPD) are most common PH population (group 3). However, efficacy of medical treatments and optimal prevention methods in this group remain uncertain. Statins such as indirect RhoA/Rho-kinase inhibitors influence one of key signalling pathways that promote PH onset. In this study, we explored protective effects of statins against PH in COPD patients using database from Taiwan National Health Insurance programme from 2002 to 2017. The main outcome was the risk of PH. The Cox proportional-hazards model and the Fine and Gray model were used to adjust covariate and competing risks to estimate the subdistribution hazard ratios (sHRs). 553,617 newly diagnosed COPD patients were stratified by statin users (n = 41,168) and statin nonusers (n = 512,449). After 1:1 propensity score matching of statin users (n = 41,163), and 41,163 statin nonusers were included for outcome analysis. Statin users had a 22% lower risk of PH than nonusers (sHR: 0.78, 95% confidence interval: 0.65-0.94). During subgroup analysis, taking higher daily doses and for a longer duration displayed a more significantly reduced risk of PH (both P for trend <0.001). Statins may have a protective effect against PH that is dose- and time-dependent.

摘要

在台湾,与慢性阻塞性肺疾病(COPD)相关的肺动脉高压(PH)患者是最常见的 PH 人群(第 3 组)。然而,该人群的医学治疗效果和最佳预防方法仍不确定。他汀类药物等间接 RhoA/Rho-激酶抑制剂影响促进 PH 发病的关键信号通路之一。在这项研究中,我们使用了来自 2002 年至 2017 年台湾全民健康保险计划的数据库,探讨了他汀类药物对 COPD 患者 PH 的保护作用。主要结局是 PH 的风险。Cox 比例风险模型和 Fine 和 Gray 模型用于调整协变量和竞争风险,以估计亚分布风险比(sHR)。根据他汀类药物使用者(n=41168)和他汀类药物非使用者(n=512449)将 553617 例新诊断的 COPD 患者分层。在 1:1 倾向评分匹配他汀类药物使用者(n=41163)后,将 41163 例他汀类药物非使用者纳入结局分析。他汀类药物使用者发生 PH 的风险比非使用者低 22%(sHR:0.78,95%置信区间:0.65-0.94)。在亚组分析中,较高的每日剂量和较长的用药时间显示出更显著降低 PH 的风险(趋势 P 值均<0.001)。他汀类药物可能对 PH 具有保护作用,且呈剂量和时间依赖性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647d/7033169/a73e9184b0c5/41598_2020_59828_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647d/7033169/c18a2ef9b93d/41598_2020_59828_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647d/7033169/a73e9184b0c5/41598_2020_59828_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647d/7033169/c18a2ef9b93d/41598_2020_59828_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647d/7033169/a73e9184b0c5/41598_2020_59828_Fig2_HTML.jpg

相似文献

1
Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study.他汀类药物对慢性阻塞性肺疾病患者肺动脉高压的保护作用:一项全国性回顾性、匹配队列研究。
Sci Rep. 2020 Feb 20;10(1):3104. doi: 10.1038/s41598-020-59828-0.
2
Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.他汀类药物的使用与 COPD 频繁加重患者住院加重风险的关系。
Int J Chron Obstruct Pulmon Dis. 2020 Feb 10;15:289-299. doi: 10.2147/COPD.S229047. eCollection 2020.
3
Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.他汀类药物对慢性阻塞性肺疾病患者的结肠癌具有剂量依赖性显著化学预防作用:一项基于人群的队列研究。
Oncotarget. 2016 Oct 4;7(40):65270-65283. doi: 10.18632/oncotarget.11263.
4
Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.他汀类药物对慢性阻塞性肺疾病(COPD)患者的肺癌具有剂量依赖性化学预防作用:一项基于人群的队列研究。
Oncotarget. 2016 Sep 13;7(37):59618-59629. doi: 10.18632/oncotarget.11162.
5
Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.他汀类药物在慢性阻塞性肺疾病患者中的使用与住院治疗:台湾一项基于全国人群的队列研究。
Clin Ther. 2011 Oct;33(10):1365-70. doi: 10.1016/j.clinthera.2011.08.010. Epub 2011 Oct 2.
6
Statin Use and the Risk of Dementia in Patients with Stroke: A Nationwide Population-Based Cohort Study.他汀类药物的使用与中风患者的痴呆风险:一项基于全国人群的队列研究。
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3001-3007. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.036. Epub 2018 Aug 5.
7
Association between statin use and osteoporotic fracture in patients with chronic obstructive pulmonary disease: a population-based, matched case-control study.他汀类药物使用与慢性阻塞性肺疾病患者骨质疏松性骨折的关系:基于人群的匹配病例对照研究。
Lipids Health Dis. 2020 Nov 3;19(1):232. doi: 10.1186/s12944-020-01412-6.
8
Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.他汀类药物对新发骨质疏松症风险的长期影响:一项全国范围内基于人群的队列研究。
PLoS One. 2018 May 3;13(5):e0196713. doi: 10.1371/journal.pone.0196713. eCollection 2018.
9
Statin use and risk of COPD exacerbation requiring hospitalization.他汀类药物的使用与 COPD 加重住院风险。
Am J Med. 2013 Jul;126(7):598-606.e2. doi: 10.1016/j.amjmed.2013.01.036. Epub 2013 May 16.
10
Statin therapy and upper tract urothelial carcinoma risk in hyperlipidemic patients with chronic kidney disease and end-stage kidney disease, a population-based 17-year follow-up study.基于人群的 17 年随访研究:他汀类药物治疗与血脂异常的慢性肾脏病和终末期肾脏病患者上尿路尿路上皮癌风险
Ren Fail. 2024 Dec;46(2):2402508. doi: 10.1080/0886022X.2024.2402508. Epub 2024 Sep 20.

引用本文的文献

1
Protective Effect of HMG-CoA Reductase Inhibitor Rosuvastatin on Doxorubicin-Induced Cognitive Impairment, Oxidative Stress and Neuroinflammation: Possible Role of CREB, ERK1/2, and BDNF.HMG-CoA还原酶抑制剂瑞舒伐他汀对阿霉素诱导的认知障碍、氧化应激和神经炎症的保护作用:CREB、ERK1/2和BDNF的可能作用
J Neuroimmune Pharmacol. 2025 May 13;20(1):53. doi: 10.1007/s11481-025-10213-6.
2
Biological pathways and mechanisms linking COPD and cardiovascular disease.连接慢性阻塞性肺疾病(COPD)与心血管疾病的生物学途径和机制。
Ther Adv Chronic Dis. 2025 Mar 28;16:20406223251314286. doi: 10.1177/20406223251314286. eCollection 2025.
3

本文引用的文献

1
Taiwan's National Health Insurance Research Database: past and future.台湾全民健康保险研究数据库:过去与未来。
Clin Epidemiol. 2019 May 3;11:349-358. doi: 10.2147/CLEP.S196293. eCollection 2019.
2
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
3
Statin use and risk of contralateral breast cancer: a nationwide cohort study.他汀类药物的使用与对侧乳腺癌风险:一项全国性队列研究。
Magnesium Sulfate, Rosuvastatin, Sildenafil and Their Combination in Chronic Hypoxia-Induced Pulmonary Hypertension in Male Rats.
硫酸镁、瑞舒伐他汀、西地那非及其联合用药对雄性大鼠慢性低氧性肺动脉高压的影响
Life (Basel). 2024 Sep 20;14(9):1193. doi: 10.3390/life14091193.
4
Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review.与慢性阻塞性肺疾病相关的肺外合并症:综述。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 29;19:567-578. doi: 10.2147/COPD.S447739. eCollection 2024.
5
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy.慢性阻塞性肺疾病中的心血管疾病:从诊断、患病率到治疗
Life (Basel). 2023 May 31;13(6):1299. doi: 10.3390/life13061299.
6
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease.慢性阻塞性肺疾病合并心血管疾病的发病机制及药物治疗分析
Front Med (Lausanne). 2022 Nov 4;9:979959. doi: 10.3389/fmed.2022.979959. eCollection 2022.
7
Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database.利用行政索赔数据库识别与 COPD 或ILD 相关的第 3 组肺动脉高压患者。
Lung. 2022 Apr;200(2):187-203. doi: 10.1007/s00408-022-00521-6. Epub 2022 Mar 29.
8
Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis.他汀类药物治疗特发性肺纤维化的研究进展。
Oxid Med Cell Longev. 2022 Mar 19;2022:6197219. doi: 10.1155/2022/6197219. eCollection 2022.
9
Chinese Herbs and Repurposing Old Drugs as Therapeutic Agents in the Regulation of Oxidative Stress and Inflammation in Pulmonary Diseases.中药及旧药新用作为治疗剂在调节肺部疾病氧化应激和炎症中的应用
J Inflamm Res. 2021 Mar 4;14:657-687. doi: 10.2147/JIR.S293135. eCollection 2021.
10
Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease.他汀类药物用于治疗慢性阻塞性肺疾病患者的肺动脉高压
Front Pharmacol. 2021 Jan 8;11:613761. doi: 10.3389/fphar.2020.613761. eCollection 2020.
Br J Cancer. 2018 Nov;119(10):1297-1305. doi: 10.1038/s41416-018-0252-1. Epub 2018 Oct 24.
4
Rural-urban disparities in family physician practice patterns: A nationwide survey in Taiwan.城乡家庭医生执业模式差异:台湾全国性调查。
Int J Health Plann Manage. 2019 Jan;34(1):e464-e473. doi: 10.1002/hpm.2662. Epub 2018 Sep 20.
5
Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.在事件发生时间分析中考虑竞争风险的重要性:在老年房颤患者回顾性队列研究中对中风风险的应用
Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004580. doi: 10.1161/CIRCOUTCOMES.118.004580.
6
Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes-A Nationwide Cohort Study.2型糖尿病患者中二甲双胍与结直肠癌发生之间的剂量依赖关系——一项全国性队列研究
Transl Oncol. 2018 Apr;11(2):535-541. doi: 10.1016/j.tranon.2018.02.012. Epub 2018 Mar 7.
7
Statins in the treatment of COPD and asthma-where do we stand?他汀类药物在 COPD 和哮喘治疗中的应用——我们处于什么位置?
Curr Opin Pharmacol. 2018 Jun;40:26-33. doi: 10.1016/j.coph.2018.01.001. Epub 2018 Jan 13.
8
Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.慢性阻塞性肺疾病患者吸入长效支气管扩张剂与心血管风险的相关性:一项巢式病例对照研究。
JAMA Intern Med. 2018 Feb 1;178(2):229-238. doi: 10.1001/jamainternmed.2017.7720.
9
The Effects of Statins on Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.他汀类药物对慢性阻塞性肺疾病患者肺动脉压的影响:一项随机对照试验。
J Res Pharm Pract. 2017 Jan-Mar;6(1):27-30. doi: 10.4103/2279-042X.200985.
10
A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.一项前瞻性随机研究:瑞舒伐他汀对慢性阻塞性肺疾病合并肺动脉高压患者疗效的评估。
Indian J Pharmacol. 2016 Sep-Oct;48(5):503-508. doi: 10.4103/0253-7613.190721.